Maja Artandi, MD

Publications

• TERT promotes epidermal proliferation through transcriptional control of a Myc- and Wnt-related developmental program. Choi, J., Southworth, Sarin, K., Venteicher, A.S., Ma, W., Chang, W., Cheung, P., Jun, S., Artandi, M.K., Shah, N., Kim, S. PLoS Genet. 2008: (4) 1
• Conditional telomerase induction causes proliferation of hair follicle stem cells. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E, Artandi MK, Oro AE, Artandi SE. Nature. 2005; 436 (7053): 1048-52
• Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo clinic regimen in the first line therapy of advance colorectal cancer Graeven U.,, Ridwelski K., Artandi M., Espana P., Scholmerich J et al. Oncol Rep. 2005: 13 (4) 681-8
• Constitutive telomerase expression promotes mammary carcinomas in aging mice. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, Greenberg RA, Castrillon DH, Horner JW, Weiler SR, Carrasco RD, DePinho RA. Proc Natl Acad Sci U S A. 2002; 99 (12): 8191-6
• Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Kubicka S, Rudolph KL, Tietze MK, Lorenz M, Manns M. Hepatogastroenterology. 2001 May-Jun; 48 (39): 783-9
• Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area Kubicka S.,, Rudolph KL., Hanke T., Tietzke MK., Tillmann H.., Trautwein C., Manns M.,. Liver. 2000: 20 (4):312-8
• IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas. Tietze MK, Wuestefeld T, Paul Y, Zender L, Trautwein C, Manns MP, Kubicka S. Cancer Gene Ther. 2000; 7 (10): 1315-23
• Murine models of malignant melanoma. Tietze MK, Chin L. Mol Med Today. 2000; 6 (10): 408-10
• NfkB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis Kuehnel F.,, Zender L., Paul Y., Tietzke MK., Trautwein C., Manns M., Kubicka S.,. J Biol Chem. 2000: 275:6421-7